Iwasaki H, Liu Y P, Nojyo Y, Ueda T, Nakamura T
First Department of Internal Medicine, Fukui Medical School, Japan.
Anticancer Res. 1995 Jan-Feb;15(1):133-9.
The effect of antileukemic agents is explained mainly by the inhibition of DNA synthesis, which may reflect the structural alteration of the target cells. To identify such cellular alterations, in particular morphologic changes associated with the exposure to antileukemic agents were investigated in the murine leukemic L1210 cell line using flow cytometry and image analysis. Cells were cultured with eight kinds of antileukemic agents in cytostatic concentrations which are clinically achievable. Living cells were observed in culture without fixation or staining. Two parameters related to cell size and shape were measured simultaneously by the image analysing computer. These parameters provided us with different criteria for characterizing the antimetabolites, DNA-strand-damage inducers and other agents tested. Such morphologic studies may make it possible to estimate the characteristics of various antileukemic agents.
抗白血病药物的作用主要通过抑制DNA合成来解释,这可能反映了靶细胞的结构改变。为了识别这种细胞改变,特别是使用流式细胞术和图像分析在小鼠白血病L1210细胞系中研究了与接触抗白血病药物相关的形态学变化。细胞用临床上可达到的细胞抑制浓度的八种抗白血病药物进行培养。在未固定或染色的情况下观察培养中的活细胞。通过图像分析计算机同时测量与细胞大小和形状相关的两个参数。这些参数为表征抗代谢物、DNA链损伤诱导剂和其他测试药物提供了不同的标准。这种形态学研究可能使估计各种抗白血病药物的特性成为可能。